Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,847 | 35,794 | 31,167 | 51,811 | 49,985 |
| Marketable Securities | 42,535 | 52,995 | 73,944 | 101,368 | 110,525 |
| Receivables | 33,377 | 22,692 | 12,103 | 6,239 | 1,775 |
| Inventories | 13,313 | 11,928 | 10,380 | 5,286 | 1,439 |
| Other current assets | 927 | 1,293 | 0 | 1,199 | 974 |
| TOTAL | $125,780 | $136,035 | $134,202 | $172,255 | $171,230 |
| Non-Current Assets | |||||
| PPE Net | 484 | 526 | 585 | 648 | 715 |
| Intangibles | 16,836 | 16,836 | 16,836 | 16,836 | 16,836 |
| Other Non-Current Assets | 14,421 | 14,502 | 13,075 | 13,361 | 12,195 |
| TOTAL | $31,741 | $31,864 | $30,496 | $30,845 | $29,746 |
| Total Assets | $157,521 | $167,899 | $164,698 | $203,100 | $200,976 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 21,187 | 20,851 |
| Accounts payable and accrued liabilities | 9,794 | 18,961 | 11,433 | 13,263 | 11,786 |
| Accrued Expenses | 33,711 | 27,642 | 24,227 | 17,957 | 17,582 |
| Other current liabilities | 242 | 252 | 261 | 731 | 500 |
| TOTAL | $44,613 | $47,808 | $36,855 | $54,054 | $51,502 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 42,620 | 41,707 | 40,104 | 38,897 | 6,282 |
| TOTAL | $42,620 | $41,707 | $40,104 | $38,897 | $6,282 |
| Total Liabilities | $87,233 | $89,515 | $76,959 | $92,951 | $57,784 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 96,271 | 96,119 | 90,577 | 89,806 | 89,368 |
| Common Shares | 961 | 960 | 898 | 893 | 893 |
| Retained earnings | -786,660 | -772,838 | -745,496 | -716,710 | -680,436 |
| Other shareholders' equity | -24,215 | -23,756 | -23,167 | -25,951 | -25,943 |
| TOTAL | $70,288 | $78,384 | $87,739 | $110,149 | $143,192 |
| Total Liabilities And Equity | $157,521 | $167,899 | $164,698 | $203,100 | $200,976 |